Dr. Amar Desai to Lead Optum Health as New CEO

Dr. Amar Desai to Lead Optum Health as New CEO

After less than six months in his role as president of health care delivery at CVS Health, Dr. Amar Desai is returning to UnitedHealth Group as the new CEO of Optum Health. The shift in leadership comes as Optum Health is growing its presence in the home health and hospice market. The company recently acquired two of the largest providers in the space – LHC Group and Amedisys Inc. – with price tags of $6 billion and more than $3.7 billion, respectively. In his role as Optum’s CEO, Dr. Desai will oversee operations of the company’s nearly 135,000 employees that provide home health, hospice and other services to 103 million patients nationwide. “I am looking forward to working with our... Read More »
Option Care Health to Merge With Amedisys in $3.6 Billion Deal

Option Care Health to Merge With Amedisys in $3.6 Billion Deal

Option Care Health, Inc. and Amedisys, Inc. announced that they have entered into a definitive merger agreement to combine in an all-stock transaction that values Amedisys at approximately $3.6 billion, including the assumption of net debt. Upon closing, Option Care Health stockholders will own 64.5% of the combined company, and Amedisys stockholders will own 35.5%. Together, Option Care Health and Amedisys will have a national clinical workforce of more than 16,500 professionals and 674 care centers across the United States. Based on recently reported 2022 financial results, the combined company generated revenues of approximately $6.2 billion and adjusted EBITDA of approximately $622... Read More »
Amedisys Buys Contessa Health

Amedisys Buys Contessa Health

The home health and hospice giant Amedisys, Inc. (NASDAQ: AMED) is back with a new deal. Earlier in July, the company announced it was buying Contessa Health, which specializes in hospital-at-home and skilled nursing facility at-home services, for $250 million, or about 3.9x Contessa’s forecasted 2022 revenues of $64 million. And Amedisys expects that by 2025, revenues will grow by 118%.  This is a good opportunity for Amedisys because it gives the company a larger foothold in the in-home services market, increasing its Total Available Market (TAM) from $44 billion to $73 billion, and provides a myriad of new services such as analytics, underwriting and care coordination. Perhaps most... Read More »
Amedisys Buys Contessa Health

Amedisys Acquires VNA Home Health Business

The home health giant Amedisys, Inc. (NASDAQ: AMED) announced last week it was acquiring the home health business of Visiting Nurse Association in Omaha, Nebraska. The business has 400 providers serving Omaha, Council Bluffs and surrounding communities.  The financial terms of the deal were not disclosed, although the companies said they expect the deal to close on or around July 1.  Amedisys provides personalized home health, hospice and personal care. The company has approximately 21,000 employees in 514 care centers within 39 states and the District of Columbia who deliver care. Amedisys purchased the business from VNA because it was looking to expand its presence in the Omaha and... Read More »
Amedysis Expands its Hospice Footprint

Amedysis Expands its Hospice Footprint

Amedysis, Inc. (NASDAQ: AMED) is expanding hospice services. The Baton Rouge, Louisiana-based home care company just acquired AseraCare Hospice in Plano, Texas. Hospice has been an increasing focus for Amedysis, which has long concentrated on personal home care services. Founded in 1994, AseraCare Hospice cares for more than 2,100 patients daily and employs more than 1,200 hospice professionals in 44 locations across 14 states, generating approximately $117 million in annual revenues. It is the hospice subsidiary of skilled nursing facility operator Golden Living, formerly Beverly Enterprises. Amedysis agreed to a purchase price of $235 million for 100% ownership. The price includes a $32... Read More »